跳至主要内容
临床试验/CTRI/2022/03/041337
CTRI/2022/03/041337尚未招募2/3 期

A single arm clinical trial to evaluate the antipyretic effect of febrikid tablets in febrile children

Dr Shraddha Detroja1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2022年1月4日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
150
试验地点
1
主要终点
Reduction in Fever and body temperature

研究概览

简要总结

This trial is designed to evaluate the efficacy of Ayurveda Antipyretic for children

As there is need of hour to develop the Ayurveda antipyretic drug which act quickly

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
5.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Patient of either gender suffering from fever of age 5 to 12 years 2) Acute onset fever of 1 to 3 days 3) Temperature between 99 to 103 Fahrenheit 4) Children with parents who agree to participate and sign the informed consent.

排除标准

  • Fever more than 103 Fahrenheit 2) Any febrile condition of children requiring an immediate intervention depending on history and general condition at the point of examination as found by the investigator will be excluded from study.

结局指标

主要结局

Reduction in Fever and body temperature

时间窗: At base line | On Day 2 | Day 3 | Day 5

Reduction in body ache and headache

时间窗: At base line | On Day 2 | Day 3 | Day 5

improvement in appetite

时间窗: At base line | On Day 2 | Day 3 | Day 5

次要结局

  • improvement in Leg cramps(Improvement in weakness)

研究者

发起方
Dr Shraddha Detroja
申办方类型
Other [Self ]

研究点 (1)

Loading locations...

相似试验